Surender Singh Jadav Selected Research

emopamil (levemopamil)

2/2021

A perspective on medicinal chemistry approaches towards adenomatous polyposis coli and Wnt signal based colorectal cancer inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Surender Singh Jadav Research Topics

Disease

3	Neoplasms (Cancer) 03/2019 - 01/2013
1	Lung Neoplasms (Lung Cancer) 09/2022
1	Colorectal Neoplasms (Colorectal Cancer) 02/2021
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 07/2020
1	Infections 11/2017
1	Edema (Dropsy) 01/2017
1	Ebola Hemorrhagic Fever 01/2015
1	Extensively Drug-Resistant Tuberculosis 01/2015
1	Tuberculosis (Tuberculoses) 01/2015

Drug/Important Bio-Agent (IBA)

2	VaccinesIBA 11/2017 - 01/2015
2	Pharmaceutical PreparationsIBA 11/2017 - 01/2015
1	Antineoplastic Agents (Antineoplastics)IBA 09/2022
1	emopamil (levemopamil)IBA 02/2021
1	CateninsIBA 02/2021
1	Proteins (Proteins, Gene)FDA Link 02/2021
1	Carrier Proteins (Binding Protein)IBA 02/2021
1	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 07/2020
1	TubulinIBA 03/2019
1	Cyclin-Dependent Kinase 4IBA 03/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	CarrageenanIBA 01/2017
1	LigandsIBA 01/2015
1	Antitubercular AgentsIBA 01/2015
1	CurcuminIBA 01/2013

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2015
1	Therapeutics 01/2013